Search Results for: epithelioid

  • |

    Mesothelioma Treatment Provides Survival Advantage to Women

    A new study suggests that women have a survival advantage over men when it comes to treatment for the most common type of malignant pleural mesothelioma. Although as many as 90 percent of people who contract the asbestos-linked cancer are men, women who contract the disease in its most common form are more likely to respond well to aggressive treatment.  The study published in the Annals of Thoracic Surgery reviewed 702 cases of malignant pleural mesothelioma.  Of those, 145 were women. The researchers found a definite difference in survival for men and women with one type of mesothelioma but they found no gender difference with the other type. Among the 450 men and women with the most common histological type…

  • |

    Researchers Learn How Selenite Combats Mesothelioma

    Sodium selenite, the most common water-soluble form of selenium, is an antioxidant and redox-modulating compound that can kill mesothelioma cells in cell cultures. Now researchers are discovering why it works. This could potentially lead to new treatments for mesothelioma. Investigators from the Karolinska Institutet in Stockholm, Sweden previously discovered that selenite triggers the death of mesothelioma cells, particularly sarcomatoid cells, which are the least common but deadliest form of this cancer. In the current study, which was published in the Journal of Experimental & Clinical Cancer Research, the investigators aimed to determine the pathways by which selenite kills mesothelioma cells, and why sarcomatoid cells seem to be most sensitive to selenite treatment. “Developing anticancer drugs is difficult,” explains Gustav Nilsonne,…